Monarch Medical Technologies
Led the company through to a strategic divestment to a clinically aligned acquirer.
I'm Charles Cornish, a hands on CEO who leads early-stage and turnaround businesses out of trouble and into the hands of the natural owners, or follow-on investments.
Both companies had underutilized assets that required strong leadership, clear strategy, people-first execution in order to attract and execute on exits to strategic buyers.
Led the company through to a strategic divestment to a clinically aligned acquirer.
Relaunched the business and led it to acquisition by a NASDAQ-listed medication-safety company.
From corporate finance to operating leadership across the US, Australia, and Brazil, with product reach into Europe.
I take software companies that have stalled (distressed, underperforming, or early-stage) and get them into the optimal window, then to a clean exit.
I step into the CEO seat and run the company to a strategic exit. It's the role I've played twice.
Commercialization, go-to-market, and deal structure for precision-medicine companies.
I can help bring capital to the table, drawing on follow-on investors from prior exits.
PE firms, struggling founders, frustrated investors, executive search, and strategic partners: if there's a fit, I'd like to hear from you.